MedTrace Logo

The Longitudinal Ovarian Reserve Study

NCT02395341 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2016-08-22

No results posted yet for this study

Summary

Postmenarchal female cancer patients scheduled to undergo cancer therapy may enroll in this study to assess changes in existing and novel surrogate measures of fertility potential before, during and after chemotherapy. Measures of fertility potential to be tested include ultrasound imaging for antral follicle counts and ovarian volumes, endocrine evaluation, and assessment of oxidative stress.

Conditions

  • Effects of Chemotherapy

Sponsors & Collaborators

Principal Investigators

  • Clarisa R Gracia, MD, MSCE · University of Pennsylvania

Eligibility

Min Age
15 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2009-02-28
Completion
2013-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02395341 on ClinicalTrials.gov